CCPs Will Not be a Panacea for the Risk Management of OTC Derivatives, Says SunGard Panel

Forcing all OTC derivatives trades to be centrally cleared will result in a whole host of unintended consequences, including a potential increase in systemic risk, agreed a panel of sell side firms and vendors at a recent SunGard event in London. Clearing via central counterparties (CCPs) has been on the regulatory agenda for some time (see McCreevy’s comments at the start of last year for example, see here) and many in the industry are concerned that a regulatory knee jerk reaction to the financial crisis will mean OTC trades that are not liquid enough to be centrally cleared could be forced down the CCP route.



Want to know what we have to say about this? Get free access to this and more stories by signing up for a free trial (or free access if you work at a financial institution) with no obligation below, or login if you’re already a member

Existing Users Login

Email: 
Password: 

Free User Registration

To create a free user account which grants you access to this and other free resources on A-Team Group sites, fill out and submit the form below (you will receive an email with your temporary password).

* Required
Email (as login):* 
Confirm Email:* 
First Name:* 
Last Name:* 
Company:* 
Firm Type: 
Company Type: 
Job Title: 
Job Role: 
Day Phone:* 
Mobile: 
Address:* 
Address 2: 
City:* 
State/Province/Suburb:* 
Postal Code/Zip:* 
Country:* 
Login:


Subscribe for full access